BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/26/2023 12:10:53 PM | Browse: 358 | Download: 1406
 |
Received |
|
2023-02-23 08:30 |
|
Peer-Review Started |
|
2023-02-23 08:33 |
|
First Decision by Editorial Office Director |
|
2023-05-16 10:53 |
|
Return for Revision |
|
2023-05-16 10:53 |
|
Revised |
|
2023-06-05 18:31 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-07-04 02:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-07-05 18:32 |
|
Articles in Press |
|
2023-07-05 18:32 |
|
Edit the Manuscript by Language Editor |
|
2023-07-02 13:06 |
|
Typeset the Manuscript |
|
2023-07-18 00:35 |
|
Publish the Manuscript Online |
|
2023-07-26 11:55 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Basic Study |
| Article Title |
γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Charupong Saengboonmee, Supannika Sorin, Sakkarn Sangkhamanon, Surang Chomphoo, Somsiri Indramanee, Wunchana Seubwai, Kanyarat Thithuan, Ching-Feng Chiu, Seiji Okada, Marie-Claude Gingras and Sopit Wongkham |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Research Grant for Young Talented Scholars, National Research Council of Thailand |
N41A640108 |
|
| Corresponding Author |
Charupong Saengboonmee, MD, PhD, Doctor, Doctor, Lecturer, Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 123 Mitraphap Highway, Khon Kaen 40002, Thailand. charusa@kku.ac.th |
| Key Words |
Baclofen; Cholangiocarcinoma; Diabetes mellitus; Drug repurposing; Hyperglycemia; Gamma-aminobutyric acid |
| Core Tip |
Diabetes mellitus (DM) is associated with an increased risk and progression of cholangiocarcinoma (CCA). The γ-aminobutyric acid (GABA) B2 receptor (GABBR2) was upregulated in CCA cells cultured in high glucose and in CCA tissues from patients with hyperglycemia. High GABBR2 expressions were significantly correlated with a non-papillary histotype and smaller sizes of CCA tumors. The treatment of baclofen, a GABA-B receptor agonist, significantly suppressed CCA cell proliferation and clonogenicity, suggesting that GABBR2 is a potential target for CCA treatment. Baclofen inhibited multiple kinases and signal transducers in CCA, resulting in downregulated downstream target proteins involving cell proliferation and suppression of CCA cell growth. |
| Publish Date |
2023-07-26 11:55 |
| Citation |
Saengboonmee C, Sorin S, Sangkhamanon S, Chomphoo S, Indramanee S, Seubwai W, Thithuan K, Chiu CF, Okada S, Gingras MC, Wongkham S. γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. World J Gastroenterol 2023; 29(28): 4416-4432
|
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i28/4416.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i28.4416 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
